Stephane S.
- Country
- France
- Department
- 1303:Gastro-Entérologie, Hépatologie
Research Overview
- Evaluation of Long-term Safety and Tolerability of Apraglutide in Patients with Short Bowel Syndrome-Intestinal Failure
- Efficacy and Safety of Subcutaneous Amlitelimab in Adults with Non-Responsive Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 2a/b Study
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15912 in Adults with Short Bowel Syndrome-associated Intestinal Failure
Data & Insights
Has run more than one trial at 11 of 71 partner sites.
Specializations
Gastrointestinal Disorders
The investigator specializes in treating severe digestive system conditions, with particular emphasis on short bowel syndrome (SBS) and its associated complications including intestinal failure.
- Short Bowel Syndrome Management
- Intestinal Failure Treatment
- Long-term Patient Care
The research focus includes evaluating novel therapeutic approaches for patients with compromised intestinal function.
Autoimmune Conditions
Dedicated to advancing treatment options for celiac disease, particularly focusing on cases that don't respond to conventional therapies. The investigator works with non-responsive celiac disease (NRCD) patients.
- Celiac Disease Treatment Innovation
- Gluten Sensitivity Management
- Intestinal Mucosa Recovery
Explores therapeutic interventions for improving intestinal health in autoimmune conditions.
Therapeutic Applications
Investigates the application of novel biological therapies for gastrointestinal disorders, including the evaluation of new treatment compounds for intestinal conditions.
- Biological Therapy Assessment
- Long-term Safety Monitoring
- Treatment Tolerability Studies
Focuses on developing safe and effective therapeutic solutions for chronic intestinal disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.